OGT and colorectal carcinoma: Reduction in the expression of GFPT1 and OGT, using shRNA and pharmacological approaches, leads to a decrease in cyclin D, a marker of cell cycle progression, and a significant decrease in cellular proliferation of CRC cells in 2D and 3D cultures.